Note- old diseases and conditions continue to return, such

New Post Public Reply Private Reply Replies (2) Message Board
microcaps microcaps #5594
497
Note- old diseases and conditions continue to return, such as tb, measles etc. The bubonic plague itself continues to affect Americans. e.g.,https://www.scientificamerican.com/article/100-years-of-bubonic-plague/
Plus a panoply of new diseases/conditions will continue to grow as per many sources-so whether or not NNLX's N-assay is used for the current pandemic, the N -assay will continue to be useful against a wide range of bacterial and viral conditions in the future,as NNLX has noted, especially in comparison to the more limited diagnosis afforded by the current pcr or pcp tech.

And yes, the govt contractor -whoever they are -who showed an interest in NNLX's N- assay -as per a preliminary agreement- is not likely to disappear in a week or two. I've explained ad nauseum in the past why it takes so long for things to move forward,given the required dd and communication among several disparate specialized groups who do not speak the same language.


almost all drugs have side effects and become toxic at some level of dosage. E.g., I've read that acetaminophen can cause liver failure at just 4000 mg/day (in fact in some cases as low as 2000mg/day i think i've read)=-bottles say do not exceed 4000mg/day or use with certain other drugs or take 3 or more alcoholic drinks/day. Untreated liver failure results in death.

https://www.uspharmacist.com/article/acetamin...ed-to-know

from the cited article: Acetaminophen toxicity is one of the most common causes of both intentional and unintentional poisoning in the U.S. In fact, there has been a steady increase in the incidence of acetaminophen-related toxicity over the past decade.... Acetaminophen-associated overdoses account for approximately 56,000 emergency department visits, 26,000 hospitalizations, and over 450 deaths annually.9

if such a commonly used drug as acetaminophen is so toxic then its odd that a reported side effect in just ONE wrong self diagnosed self treating patient was used in one article https://fortune.com/2020/03/20/malaria-drug-c...dly-china/ to caution against chloroquine treatment for covid 19- such a strange event/article title is more likely part of current widespread political assassination attempts.

the ff was the journal article cited by my post
https://www.sciencedirect.com/science/article...via%3Dihub

https://www.ncbi.nlm.nih.gov/pubmed/32164085
the wiki article https://en.wikipedia.org/wiki/Chloroquine notes that
a further study concluded that hydroxychloroquine was more potent than chloroquine, with a more tolerable safety profile

one article said the older less safe form of chloroquine was widely used by europeans before entering any malaria prone theater and that said europeans continued on a dosage of such for 2 months AFTER exiting malaria prone areas. Obviously- even the older less safe form of the treatment were considered an improvement compared to malaria.

Of course, today safety is emphasized more than decades ago,but in all cases drugs are intended for particular uses under a doctors direction- and are not to be used willy nilly as per a wrong self diagnosis as did the chinese woman who developed arrhythmia- which is contraindicated for chloroquine, just as a long list of drugs are contraindicated for those with heart problems. In most such cases it is the side effect which kills -often in people prone to such a side effect.
In italy i've read that up to 99% of deaths occurred in those with a previous underlying medical condition.
As French and Australian and Chinese work with chloroquine (which was also effective against some previous corona viruses) and its safer derivatives came to light it was naturally jumped on as a possible treatment modality, and it still is, since regulatory approval for all potential vaccines seems to be one year away, according to reports i've read and heard.

So non-scientists, including politicians, will in the current climate of runaway fear be glad to push such a potential treatment.
That is part of their job to calm fears in a fear prone populace.

Meanwhile scientists,who by nature must be more cautious -want to look at the studies first and determine whether other studies or tests are necessary for safety purposes before jumping into the boat. This paradigm should be well known and understood-and remember it was scientists use of chloroquine or its safer derivatives and their scientific statements that such use was highly effective against the virus in their studies/samples that got politicians and others excited,as it should-why -because we cannot idly sit by and wait one year for a vaccine to be approved before we start to combat the virus. That should be obvious.



Nanologix Inc (NNLX) Stock Research Links

NNLX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sacrifice Unending: 9/11's Lingering Health Toll

Updated Category News Views 1

The Unseen Toll of 9/11 on the Firefighter Community Two and a half decades since that fateful morning of September 11, 2001, we're staring at a grim reality. The heroic souls of the New York City Fire Department (FDNY)—those who ran toward peril when others ran away—are still paying the price. Incredibly, more than 400 FDNY members have succumbed to World Trade...

Continue Reading
South Florida Donor Network Honors 52 Heroic Donors

Updated Category News Views 4

A Heartfelt Tribute to Lifesavers You ever been to a gathering that reminds you how deeply human connections run? That's what happened at The Diplomat Beach Resort in Hollywood. South Florida Donor Network (SFDN) pulled together a ceremony honoring 52 donor heroes whose legacies beat strong through the recipients living thanks to their gifts. An Event Worth Attending...

Continue Reading
Maurices Strengthens Position with Key Refinancing Deal

Updated Category News Views 2

Maurices' Bold Financial Maneuver When a retailer like Maurices, with its near-century-long history, decides to play in the financial arena, it sure makes my ears perk up. This Duluth-based women's fashion retailer isn't just dipping its toes in—it's executing a full-blown refinancing blitzkrieg and coming out stronger. Announcing the completion of its refinancing plan...

Continue Reading
Agroz's Big Leap: New Supply Deal in Malaysia

Updated Category News Views 3

Agroz Inc. Executes a Game-Changing Deal If anyone thought the ag tech players were sitting idle, think again. Agroz Inc., noted for their innovative controlled-environment agriculture, just inked a pivotal deal with Harvest Hive in Malaysia. It's not just a nod to expansion—it's a strategic leap into the big leagues. Picture this: Harvest Hive's sprawling 500-acre farm...

Continue Reading
ZEEKR's Shooting Brakes Dominate: Over 400K Sold

Updated Category News Views 3

ZEEKR's Stellar Performance in a Crowded Market Another month, another bumper crop for ZEEKR's shooting brakes. These beauties aren't just hanging in there; they're leading the pack. In August alone, global deliveries marched past the 10,000 mark for the third month running—a feat not easily achieved in today's saturated automotive landscape. It's no wonder the...

Continue Reading
Veho's Role in Redefining Beauty E-Commerce Delivery

Updated Category News Views 1

Veho Grabs Headlines with BeautyMatter Awards Nod Here's something a bit off the beaten path: Veho's been tapping into new wells of opportunity in the e-commerce sector, and their latest accolade demonstrates just that. Named a finalist in the 2026 BeautyMatter Awards under the Logistics category, they're making noise in all the right circles. Beyond Boxes: Transforming...

Continue Reading
Sandbox VR Expands to Melbourne, Betting on Immersive Fun

Updated Category News Views 1

Sandbox VR Ventures into Melbourne's Heart Every now and then, a venture takes its ambitions and rolls the dice on a prime location. Sandbox VR is swaggering into Melbourne's bustling Central Business District, fresh out of its success on the Gold Coast. Opening this Melbourne venue on September 14 marks a significant leap in the company's Aussie expansion—a bold nod to...

Continue Reading
WNET's 25th Anniversary 9/11 Tribute: Stories and Lessons

Updated Category News Views 2

Reflecting on a Dark Day with WNET's Programming Nothing quite hits you like the anniversary of a colossal tragedy. The memories of September 11, 2001, remain etched in the urban landscape of New York City, and this year marks 25 years since that heart-wrenching day. The WNET Group steps up to the plate with a comprehensive slate of programming aimed at honoring the...

Continue Reading
LeoLabs and SciTec Partner for $93.7M Space Force Deal

Updated Category News Views 2

LeoLabs and SciTec Join Forces for Space Dominance The space race ain't just about rockets blasting off anymore. It's about making sure we've got eyes everywhere, even on the back of our heads, so to speak. Enter LeoLabs teaming up with SciTec to help the U.S. Space Force upgrade their radar systems to something out of a sci-fi flick, armed with a $93.7 million contract...

Continue Reading
MCatalysis Secures $5M to Disrupt Fuel Cost Dynamics

Updated Category News Views 3

Funding Fuels Innovation MCatalysis has just secured a hefty $5 million in seed funding to throw down with the big dogs in energy production. This isn't your regular backyard science project; this company is serious about changing the game with a tech-driven approach that could undercut current fuel prices. HL Energy Ventures and Oxford Science Enterprises are backing...

Continue Reading

Top 5 Most Recently Viewed Articles

Valiant Finance's US Expansion: Joe Iavarone at the Helm

Updated Category News Views 142

Valiant Finance just scored a major play on Feb 17, 2026, by appointing Joe Iavarone as their North American President for Sales & Marketing. This isn't just another hire; it’s nearly 30 years of vendor finance expertise coming into play for a company that's already pushed out over $3 billion in loans. Now they're eyeing a slice of the massive $1.3 trillion equipment...

Continue Reading
C-Ray Therapeutics Unveils Promising Alpha Therapy Data at EANM

Updated Category News Views 303

C-Ray Therapeutics Showcases New Clinical Insights on Alpha Therapy During the recent Annual Congress of the European Association of Nuclear Medicine (EANM 2025) held in Barcelona, C-Ray Therapeutics (Shanghai) Co., Ltd. presented groundbreaking clinical findings related to its innovative radiopharmaceutical, 225Ac-PSMA-CY313, aimed at treating metastatic...

Continue Reading
Viking M&A Launches New Office, Enhancing Local Business Support

Updated Category News Views 216

Viking M&A Expands to Serve Local Business Owners Business owners can now access premier mergers and acquisitions expertise with the opening of Viking Mergers & Acquisitions' latest office. This significant development marks the firm's sixteenth location, illustrating its dedication to assisting small and mid-sized business owners in effectively navigating the...

Continue Reading
NACD Invites Nominations for the Prestigious 2025 Awards

Updated Category News Views 298

Nominations Open for 2025 NACD Directorship 100™ Awards The nomination period for the 2025 NACD Directorship 100™ Awards is officially open, inviting individuals who have made significant contributions to corporate governance to participate. The closing date for nominations is June 30, 2025, providing ample time for worthy candidates to be recognized. Overview of NACD...

Continue Reading
Composite Decking Market Sees USD 2.82 Billion Growth by 2028

Updated Category News Views 79

Composite Decking Market Expansion Analysis The global composite decking market is navigating a transformative phase, projected to grow by a significant USD 2.82 billion between 2024 and 2028. With a compound annual growth rate (CAGR) of 14.04%, this market expansion is largely attributed to the revival of the construction industry and an increasing demand for...

Continue Reading